Results 81 to 90 of about 217,050 (318)

A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity [PDF]

, 2021
Vincent Legros, Solène Denolly, Manon Vogrig, Bertrand Boson, Eglantine Siret, Josselin Rigaill, Sylvie Pillet, Florence Grattard, Sylvie Gonzalo, Paul O. Verhoeven, Omran Allatif, P. Berthelot, Carole Pélissier, Guillaume Thiéry, Élisabeth Botelho-Nevers, Guillaume Y. Millet, Jérôme Morel, Stéphane Paul, Thierry Walzer, François‐Loïc Cosset, Thomas Bourlet, Bruno Pozzetto   +21 more
openalex   +1 more source

Neutralizing antibody responses.

, 2015
Neutralizing antibody responses in vaccinees four weeks after the second HIV-MVA boost vaccination as determined using the pseudovirus/TZMbl assay versus the IMC/PBMC assay (A).
Bernard Moss (132301), Christina Ochsenbauer (161594), Mary A. Marovich (102258), Eligius F. Lyamuya (311596), Gunnel Biberfeld (512861), Eric Sandström (3169440), Fred Mhalu (355916), Guido Ferrari (164054), Charlotta Nilsson (563943), Said Aboud (214830), Victoria R. Polonis (132293), Merlin L. Robb (132305), Muhammad Bakari (316249), Agricola Joachim (723257), Patricia Earl (237325), Britta Wahren (2324)   +15 more
core   +1 more source

Mechanically Spatio‐Chimeric Fibrin Assembly Enables Vascular‐Integrated Muscle Reconstruction for Volumetric Muscle Loss Repair

Advanced Materials, EarlyView.
SPARC (spatio‐chimeric, plasma‐based, anisotropic, and shear‐responsive construct) that integrates myogenic and vascular microenvironments within a single construct. The dual‐modulus matrix directs aligned myotube formation and endothelial network development, enabling a vascularized muscle implant that seamlessly anastomoses with host tissue and ...
Su Hyun Jung, Minjun Kim, Da‐Yoon Kim, Min Kyu Kim, Sieun Lee, Yoonhee Jin, Joo H. Kang   +6 more
wiley   +1 more source

Neutralizing antibodies in convalescent patients [PDF]

Nature Reviews Immunology, 2020
Uhl, LFK, Chauveau, A
openaire   +3 more sources

A Reproducible and Scalable Process for High Yield Mesenchymal Stromal Cell Extracellular Vesicles Production

Advanced Materials Technologies, EarlyView.
Mesenchymal stem cell derived extracellular vesicles (MSC‐EVs) are a promising therapeutic tool for regenerative medicine. However, the field lacks a reproducible high‐yield production method to answer the quantities needed for clinical translation.
Christophe Wong, Elise Madec, Jeanne Volatron, Max Piffoux, Amanda K. A. Silva, Florence Gazeau, Jean‐Philippe Herbeuval, Thibaut Fourniols   +7 more
wiley   +1 more source

Decision letter: Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants

, 2020
D Montefiore
openalex   +1 more source

Premature stop codons in the G glycoprotein of human respiratory syncytial viruses resistant to neutralization by monoclonal antibodies [PDF]

, 1991
Paloma Rueda, Teresa Delgado, Agustı́n Portela, Jose ́A. Melero, Blanca García‐Barreno   +4 more
openalex   +1 more source

Detection of antibody-dependent complement mediated inactivation of both autologous and heterologous virus in primary HIV-1 infection

, 2005
Specific CD8 T-cell responses to human immunodeficiency virus type 1 (HIV-1) are induced in primary infection and make an important contribution to the control of early viral replication.
Aubin, K., Williams, I., Jones, N.A., Borrow, P., Holuigue, S., Cornforth, D., Wong, M., Pellegrino, P., McKnight, A., Aasa-Chapman, M.M.I., Newton, P.   +10 more
core  

Characterisation of llama antibody fragments able to act as HIV-1 entry inhibitors [PDF]

, 2009
Human immunodeficiency virus type 1 (HIV-1) entry into cells is mediated by the functional envelope spike, which consists of trimers of gp120 bound to gp41.
Forsman, A M M, Forsman, A.M.M.
core  

Magnetic Micro‐ and Nanorobots for Precision Thrombolysis: Design Strategies and Translational Challenges

Advanced Robotics Research, EarlyView.
Micro‐ and nanorobots for targeted thrombolysis. This perspective elaborates on the clinical indication of blood clot disorders and current limitations for treatment. As a novel, alternative solution, micro‐ and nanorobots can be used to treat and break down thrombi.
Joshua M. Mesfin, Yimo Yan, Nikola Cesarovic, Simone Schuerle   +3 more
wiley   +1 more source